Cipla Ltd.
| BSE: 500087 | Sector: Health care |
| NSE: CIPLA | ISIN Code: INE059A01026 |
| BSE 00:00 | 14 May | 904.10 |
5.40 (0.60%) |
OPEN
909.00 |
HIGH
920.95 |
LOW
901.00 |
| NSE 00:00 | 14 May | 904.05 |
5.45 (0.61%) |
OPEN
909.00 |
HIGH
921.00 |
LOW
900.80 |
| OPEN | 909.00 |
| PREVIOUS CLOSE | 898.70 |
| VOLUME | 790000 |
| 52-Week high | 966.00 |
| 52-Week low | 565.90 |
| P/E | 27.41 |
| Mkt Cap.(Rs cr) | 72,911 |
| Buy Price | 0.00 |
| Buy Qty | 0.00 |
| Sell Price | 0.00 |
| Sell Qty | 0.00 |
Cipla Ltd. (CIPLA) - Net Sales
Market Cap
| COMPANY | LATEST(Rs) | CHG | CHG(%) | Net Sales (Rs crore) |
| Aurobindo Pharma | 1006.60 | -9.65 | -0.95 | 13266.48 |
| Cipla | 904.10 | 5.40 | 0.60 | 12659.15 |
| Sun Pharma.Inds. | 691.10 | -11.55 | -1.64 | 12531.93 |
| Dr Reddy's Labs | 5195.85 | -106.15 | -2.00 | 11850.40 |
| Lupin | 1178.80 | -31.95 | -2.64 | 11025.66 |
| Apollo Hospitals | 3139.65 | -56.85 | -1.78 | 9794.50 |
| Glenmark Pharma. | 607.85 | -16.00 | -2.56 | 6712.63 |
| Alkem Lab | 2995.05 | 0.40 | 0.01 | 6677.08 |
| Cadila Health. | 617.10 | -29.85 | -4.61 | 6347.40 |
| Torrent Pharma. | 2722.50 | -3.15 | -0.12 | 6168.44 |
| Divi's Lab. | 4022.00 | -39.25 | -0.97 | 5310.57 |
| Ipca Labs. | 2148.35 | 11.80 | 0.55 | 4337.82 |
| Piramal Enterp. | 1633.00 | -61.60 | -3.64 | 4219.19 |
| Alembic Pharma | 938.55 | -12.35 | -1.30 | 4132.55 |
| Abbott India | 16098.30 | -16.50 | -0.10 | 4093.14 |
| Glaxosmi. Pharma | 1503.80 | 24.35 | 1.65 | 3224.68 |
| Jubilant Pharmo | 822.90 | -27.55 | -3.24 | 3139.90 |
| Sanofi India | 7747.55 | -3.55 | -0.05 | 2901.90 |
| Laurus Labs | 468.25 | -16.05 | -3.31 | 2797.34 |
| Gland Pharma | 2882.10 | 23.50 | 0.82 | 2633.24 |
Quick Links for Cipla:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
